Literature DB >> 744156

The effect of zinc on insulin metabolism.

E R Arquilla, S Packer, W Tarmas, S Miyamoto.   

Abstract

Experiments were designed to study the effect of Zn on in vivo and in vitro insulin metabolism. The in vivo experiments involved pretreating mice with either Zn or Na, followed by ip [125I]iodoinsulin injection. Pretreatment of mice with Zn resulted in an accelerated and increased magnitude of binding of [125I]iodoinsulin to the liver compared to mice pretreated with Na. Results are submitted which support the probability that the changes in the amounts of intact and degraded insulin in circulation with time are related to the binding and degradation of insulin in the liver rather than in the kidney. In vivo ip injected insulin was demonstrated to preferentially bind to the plasma membrane of the liver. Liver plasma membranes isolated from mice pretreated with Zn bound more [125I]iodoinsulin than plasma membranes of Na-pretreated mice. In vitro experiments employing isolated liver plasma membranes demonstrated that added Zn increased the binding and inhibited the degradation of insulin. Evidence is presented that supports the concept that two receptors exist, one at which degradation of [125I]iodoinsulin occurs and another at which degradation does not occur.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 744156     DOI: 10.1210/endo-103-4-1440

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  22 in total

Review 1.  Current status of zinc in health and disease states.

Authors:  P J Aggett; J T Harries
Journal:  Arch Dis Child       Date:  1979-12       Impact factor: 3.791

2.  The role of the pancreas in the regulation of zinc status.

Authors:  J P Van Wouwe; J J Uijlenbroek
Journal:  Biol Trace Elem Res       Date:  1994-08       Impact factor: 3.738

3.  Altered tissue content of trace metals in diabetic hyperinsulinaemic sand rats (Psammomys obesus).

Authors:  I Raz; J H Adler; E Havivi
Journal:  Diabetologia       Date:  1988-05       Impact factor: 10.122

4.  Influence of sulfonylureas on the secretion, disposal and effect of insulin.

Authors:  L O Almér; E Johansson; A Melander; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Insulin aggregation in aqueous media and its effect on alpha-chymotrypsin-mediated proteolytic degradation.

Authors:  F Y Liu; D O Kildsig; A K Mitra
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

6.  Phenylalaninylargininylarginine: a novel tripeptide exerting Zn(2+)-dependent, insulin-mimetic inhibitory action on myocardial proteolysis.

Authors:  L Zhang; T D Lockwood
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

7.  Effects of diabetes type and treatment on zinc status in diabetes mellitus.

Authors:  J Honnorat; M Accominotti; C Broussolle; A C Fleuret; J J Vallon; J Orgiazzi
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

Review 8.  Zinc and insulin sensitivity.

Authors:  P Faure; A Roussel; C Coudray; M J Richard; S Halimi; A Favier
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

9.  Effect of acute zinc deficiency on insulin receptor binding in rat adipocytes.

Authors:  M J Gomot; P Faure; A M Roussel; C Coudray; M Osman; A Favier
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

10.  A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.

Authors:  Yusuke Adachi; Jiro Yoshida; Yukihiro Kodera; Akira Kato; Yutaka Yoshikawa; Yoshitane Kojima; Hiromu Sakurai
Journal:  J Biol Inorg Chem       Date:  2004-09-18       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.